Decheng Capital China Life Sciences USD Fund III, L.P. — SEC Form 4 filings
SEC reporting owner CIK 1736814. 19 Form 4 filings on record with FilingPulse; latest filed 2025-10-20.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-01-22 to 2025-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 63 legs across 17 filings — 854,615 shares, $2,019,942 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 225,217 shares @ $3.16 ($711,686) in BeyondSpring Inc., filed 2025-08-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BeyondSpring Inc. (BYSI) | 10% owner | 17 | — | 63 legs · 854,615 sh · $2,019,942 | — |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) | 10% owner | 2 | — | — | 10 |
Form 4 filings — Decheng Capital China Life Sciences USD Fund III, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-20 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 85,798 @ $1.72 · Sale (S): 45,513 @ $1.76 | EDGAR |
| 2025-10-15 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 107,361 @ $1.70 · Sale (S): 28,495 @ $1.65 · Sale (S): 17,960 @ $1.65 | EDGAR |
| 2025-10-10 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 7,507 @ $1.77 · Sale (S): 3,979 @ $1.81 · Sale (S): 2,390 @ $1.77 | EDGAR |
| 2025-10-07 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 600 @ $1.76 · Sale (S): 17,500 @ $1.78 · Sale (S): 2,100 @ $1.79 | EDGAR |
| 2025-10-02 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Management II (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 4,464 @ $1.81 · Sale (S): 2,601 @ $1.80 · Sale (S): 600 @ $1.73 | EDGAR |
| 2025-09-29 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 700 @ $1.66 · Sale (S): 600 @ $1.68 · Sale (S): 500 @ $1.75 | EDGAR |
| 2025-09-24 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 5,410 @ $1.83 · Sale (S): 4,106 @ $1.72 · Sale (S): 2,256 @ $1.68 | EDGAR |
| 2025-09-19 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 2,304 @ $1.83 · Sale (S): 5,307 @ $1.74 · Sale (S): 3,656 @ $1.79 | EDGAR |
| 2025-09-16 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 700 @ $1.85 · Sale (S): 2,570 @ $1.84 · Sale (S): 840 @ $1.88 | EDGAR |
| 2025-09-11 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 9,050 @ $1.97 · Sale (S): 8,176 @ $1.93 · Sale (S): 3,820 @ $1.90 | EDGAR |
| 2025-09-08 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 803 @ $1.82 · Sale (S): 1,106 @ $1.86 · Sale (S): 7,090 @ $1.93 | EDGAR |
| 2025-09-03 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 800 @ $1.74 · Sale (S): 2,800 @ $1.78 · Sale (S): 1,270 @ $1.81 | EDGAR |
| 2025-08-28 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 2,000 @ $1.79 · Sale (S): 1,300 @ $1.78 · Sale (S): 809 @ $1.81 | EDGAR |
| 2025-08-25 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 3,034 @ $1.79 · Sale (S): 2,376 @ $1.75 · Sale (S): 300 @ $1.77 | EDGAR |
| 2025-08-20 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 47,668 @ $2.03 · Sale (S): 3,604 @ $1.77 · Sale (S): 3,456 @ $1.74 | EDGAR |
| 2025-08-15 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 2,000 @ $2 · Sale (S): 2,900 @ $2 | EDGAR |
| 2025-08-11 | 4 | BeyondSpring Inc. (BYSI) jointly with Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin | Sale (S): 5,000 @ $3.23 · Sale (S): 59,253 @ $3.17 · Sale (S): 60,000 @ $3.11 · Sale (S): 225,217 @ $3.16 · Sale (S): 1,700 @ $3.09 · Sale (S): 600 @ $2.43 · +11 more | EDGAR |
| 2024-05-20 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) jointly with Cui Xiangmin, Decheng Capital Management III (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC | Code (U): 6,582,380 · Code (U): 1,735,544 · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +2 more | EDGAR |
| 2024-01-22 | 4 | ALPINE IMMUNE SCIENCES, INC. (ALPN) jointly with Decheng Capital Management III (Cayman), LLC | Option exercise/expiry (X): 1,234,636 @ $12.74 · Option exercise/expiry (X): 1,234,636 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1736814 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →